A New Serotyping Method of Streptococcus pneumoniae Based on CRISPR/Cas9-Targeted Sequencing
Yustinus Maladan1, Endah Retnaningrum2, Budi Setiadi Daryono3
1Doctorate Program of Biology, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia.
The Journal of Molecular Diagnostics : JMD
|November 27, 2024
Summary
A novel CRISPR/Cas9-targeted sequencing method accurately identifies Streptococcus pneumoniae serotypes. This breakthrough uses targeted sequencing on the Oxford Nanopore platform for rapid and multiplexed serotyping.
Area of Science:
- Genomics
- Microbiology
- Molecular Biology
Background:
- Streptococcus pneumoniae serotyping is crucial for public health.
- High diversity in the capsular polysaccharide (cps) locus complicates traditional identification methods.
Purpose of the Study:
- To develop a novel, efficient, and accurate serotyping method for Streptococcus pneumoniae.
- To leverage CRISPR/Cas9-targeted sequencing for improved serotype identification.
Main Methods:
- CRISPR/Cas9 system designed with specific probes targeting the cps locus (approx. 20 kb region between dexB and aliA genes).
- Utilized Oxford Nanopore Technologies platform for sequencing with native barcoding for multiplexing.
- Employed de novo assembly and a new analysis pipeline, PneumoCRISPR, for sequence read reconstruction and serotyping.
Main Results:
- Successfully designed four CRISPR/Cas9 probes that accurately recognize the S. pneumoniae cps locus.
- Serotyping results demonstrated high concordance with established whole-genome sequencing data.
- The method enables multiplexed sample analysis in a single sequencing run.
Conclusions:
- The developed CRISPR/Cas9-targeted sequencing method offers a promising advancement for S. pneumoniae serotype identification.
- This technique provides a robust and efficient alternative for epidemiological surveillance and diagnostics.
- The PneumoCRISPR pipeline facilitates rapid analysis of Nanopore sequencing data for serotyping.
Related Concept Videos
CRISPR
49.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.5K
CRISPR and crRNAs
16.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.7K


